Dolutegravir and rilpivirine (TBC)

Generic Name: Dolutegravir and rilpivirine Brand Name: TBC Manufacturer: ViiV Healthcare ULC Indications: HIV infection Submission Type: New Combination Project Status: Pending Call For Patient Input: November 23, 2017 Patient Input Closed: January 19, 2018 Anticipated Date: December 21, 2017 Biosimilar: No Fee Schedule1: Pending Submit Feedback Tags infectious diseases, […]


Featured Review: Virtual reality for stroke rehabilitation

Many people after having a stroke have difficulty moving, thinking, and sensing. This often results in problems with everyday activities such as writing, walking, and driving. Virtual reality and interactive video gaming therapy involves using computer-based programs designed to simulate real-life objects and events. This may have some advantages over traditional therapy […]


Nyhetsbrev nr 5, 2017

Sidoöverenskommelser för TNF- och JAK-hämmare frigör 550 miljoner kronor årligen Landstingen, TLV och företag har genomfört trepartsöverläggningar för TNF-hämmare och JAK-hämmare. Trepartsöverläggningarna har resulterat i sidoöverenskommelser mellan landstingen och företagen om återbäring av en del av landstingens kostnader för Benepali, Enbrel, Erelzi, Humira, Olumiant och Xeljanz. Läs mer här  Nu […]


[Alectinib (non-small-cell lung cancer) – addendum to commission A17-19]

Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen. Alectinib (nicht kleinzelliges lungenkarzinom): addendum zum auftrag A17-19; auftrag […]


[Osimertinib (lung cancer) – addendum to commission A17-20]

Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen. Osimertinib (nicht kleinzelliges Lungenkarzinom): addendum zum auftrag A17-20; auftrag […]


[Tofacitinib (rheumatoid arthritis) – addendum to commission A17-18]

Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen. Tofacitinib (rheumatoide arthritis): addendum zum auftrag A17-18; auftrag A17-4. […]


buprenorphine hydrochloride (Probuphine)

Generic Name: buprenorphine hydrochloride Brand Name: Probuphine Manufacturer: Knight Therapeutics Inc. Indications: opioid drug dependence Submission Type: New Project Status: Pending Call For Patient Input: November 22, 2017 Patient Input Closed: January 18, 2018 Anticipated Date: December 20, 2017 Biosimilar: No Fee Schedule1: Pending Submit Feedback Tags mental health, addiction


fluocinolone acetate (Iluvien)

Generic Name: fluocinolone acetate Brand Name: Iluvien Manufacturer: Knight Therapeutics Inc. Indications: Diabetic macular edema (DME) Submission Type: New Project Status: Pending Call For Patient Input: November 22, 2017 Patient Input Closed: January 18, 2018 Anticipated Date: December 20, 2017 Biosimilar: No Fee Schedule1: Pending Submit Feedback Tags eye, diabetes


Neuromuscular electrical stimulation for the prevention of venous thromboembolism

We included in the review five randomised controlled trials and three quasi-randomised trials, enrolling a total of 904 participants. Among these, four studies included patients undergoing major surgical procedures; one study included patients undergoing surgery for hip fracture under spinal anaesthesia; one study included trauma patients with a contraindication for […]


Treatments for spasticity (overactive muscle contractions) following brain injury

Review question We reviewed the evidence about the effect of treatments (drug and non-drug) for spasticity following a brain injury caused by a blow to the head (traumatic brain injury (TBI)). Background Many people with TBI experience muscle spasticity, when their muscles contract or tighten involuntarily. This can impact on […]


AmerisourceBergen says civil penalty to resolve DOJ probe now at $625M

It turns out that the quarter-crushing $575 million that drug wholesaler AmerisourceBergen set aside to settle civil litigation with the Justice Department was not enough. It is going to take another $50 million. That comes on top of the $260 million the drug distributor has already paid to resolve a […]


ICER Releases Report on Tardive Dyskinesia Treatments

The Institute for Clinical and Economic Review (ICER) on Tuesday released an Evidence Report assessing the comparative clinical effectiveness and value of three vesicular monoamine transporter-2 (VMAT2) inhibitors for management of tardive dyskinesia (TD), a movement disorder often associated with long-term use of certain antipsychotic drugs. The report reviews evidence […]


Dr. Darrell Abernethy of FDA Drug Safety Dies

Dr. Darrell Abernethy, a champion of drug safety, died Saturday of pancreatic cancer. Dr. Abernathy made significant contributions to the healthcare field, as a researcher, educator, and internist specializing in geriatric medicine. Abernathy most recently worked at the U.S. Food and Drug Administration to develop approaches to predict adverse effects […]


Sunovion highlights epilepsy heroes in reupped awareness campaign

Sunovion is looking for a hero. Epilepsy heroes, that is. Its “My Epilepsy Hero” campaign, now in its second year, encourages patients and caregivers to share their hero stories and even gives them a cape with a custom Facebook frame. Sunovion first partnered on the campaign with the Epilepsy Foundation […]